FDA-approved Levophed as an alternative multitargeted therapeutic against cervical cancer transferase, cell cycle, and regulatory proteins. - Nagmi Bano; Shaban Ahmad; Dinesh Gupta; Khalid Raza (Comput. Biol. Medicine, 2025)